NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
Apr 21 01:34PM ET
7.20
Dollar change
-0.08
Percentage change
-1.10
%
Index- P/E- EPS (ttm)-19.54 Insider Own9.21% Shs Outstand3.38M Perf Week15.76%
Market Cap25.35M Forward P/E- EPS next Y-18.34 Insider Trans0.00% Shs Float3.20M Perf Month-31.63%
Income-41.84M PEG- EPS next Q-3.54 Inst Own6.21% Short Float3.93% Perf Quarter-40.17%
Sales0.00M P/S- EPS this Y23.63% Inst Trans- Short Ratio2.02 Perf Half Y-50.10%
Book/sh5.65 P/B1.27 EPS next Y-23.18% ROA-87.51% Short Interest0.13M Perf Year-83.06%
Cash/sh8.60 P/C0.84 EPS next 5Y2.13% ROE-182.35% 52W Range5.35 - 49.27 Perf YTD-33.63%
Dividend Est.- P/FCF- EPS past 5Y50.16% ROI-153.45% 52W High-85.39% Beta-1.56
Dividend TTM- Quick Ratio2.21 Sales past 5Y0.00% Gross Margin- 52W Low34.59% ATR (14)0.85
Dividend Ex-Date- Current Ratio2.21 EPS Y/Y TTM-220.54% Oper. Margin- RSI (14)38.38 Volatility10.64% 11.57%
Employees25 Debt/Eq0.80 Sales Y/Y TTM- Profit Margin- Recom2.00 Target Price94.00
Option/ShortNo / Yes LT Debt/Eq0.43 EPS Q/Q9.72% Payout- Rel Volume0.75 Prev Close7.28
Sales Surprise- EPS Surprise-23.08% Sales Q/Q- EarningsMar 27 AMC Avg Volume62.12K Price7.20
SMA20-13.95% SMA50-27.68% SMA200-49.77% Trades Volume29,824 Change-1.10%
Date Action Analyst Rating Change Price Target Change
Apr-10-25Downgrade Scotiabank Sector Outperform → Sector Perform
Apr-10-25Downgrade H.C. Wainwright Buy → Neutral
Mar-14-24Initiated Scotiabank Sector Outperform $13
Feb-08-24Initiated Jefferies Buy $15
Today 08:00AM
Apr-10-25 11:05AM
Apr-09-25 04:30PM
Mar-27-25 04:10PM
Mar-25-25 04:30PM
08:00AM Loading…
Mar-13-25 08:00AM
Feb-10-25 08:00AM
Feb-07-25 04:30PM
Jan-06-25 08:00AM
Dec-06-24 04:30PM
Dec-05-24 09:00PM
Nov-25-24 04:30PM
Nov-12-24 04:21PM
08:00AM
Oct-10-24 07:01AM
07:00AM Loading…
07:00AM
Sep-20-24 04:30PM
Sep-18-24 08:00AM
Sep-05-24 08:00AM
Aug-23-24 04:30PM
Aug-21-24 08:00AM
Aug-15-24 08:00AM
Aug-08-24 04:56PM
Jun-20-24 08:13AM
08:00AM
07:28AM
Jun-18-24 06:22PM
Jun-07-24 04:30AM
May-21-24 08:00AM
May-09-24 04:29PM
04:05PM Loading…
Apr-26-24 04:05PM
Apr-09-24 08:00AM
Apr-04-24 08:00AM
Mar-19-24 09:53PM
04:25PM
Mar-12-24 08:00AM
Mar-05-24 04:30PM
Feb-26-24 08:00AM
Feb-02-24 04:30PM
Jan-05-24 04:05PM
Dec-01-23 04:15PM
Nov-20-23 08:00AM
Nov-08-23 05:17PM
Oct-12-23 08:25AM
Oct-11-23 04:29PM
08:01AM
08:00AM
07:41AM
Oct-10-23 04:05PM
Sep-19-23 08:00AM
Sep-05-23 08:00AM
Aug-10-23 04:13PM
Jul-19-23 08:00AM
May-31-23 04:05PM
May-25-23 05:00PM
May-19-23 04:05PM
May-10-23 04:15PM
Apr-28-23 08:00AM
Apr-27-23 04:58PM
Apr-26-23 06:41PM
Apr-17-23 09:00AM
Mar-22-23 05:26PM
Mar-15-23 04:05PM
Mar-14-23 04:30PM
Nov-22-22 04:05PM
Nov-10-22 09:00AM
Nov-08-22 08:00AM
Nov-02-22 08:00AM
Oct-06-22 08:00AM
Sep-07-22 08:00AM
Aug-15-22 08:00AM
Jul-07-22 08:00AM
Jun-09-22 08:00AM
Jun-06-22 04:05PM
May-26-22 04:57PM
May-13-22 08:00AM
Apr-27-22 10:01AM
08:00AM
Apr-08-22 01:00PM
Mar-29-22 04:00PM
Mar-10-22 08:00AM
Mar-08-22 04:30PM
Feb-09-22 08:00AM
Nov-18-21 08:00AM
Nov-12-21 07:00AM
Nov-10-21 04:05PM
Nov-09-21 08:00AM
Nov-08-21 08:00AM
Oct-01-21 08:00AM
Sep-20-21 08:00AM
Sep-13-21 08:00AM
Sep-09-21 04:01PM
Aug-12-21 04:01PM
Aug-09-21 08:00AM
Jul-09-21 08:00AM
Jul-01-21 04:00PM
Tempest Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development and discovery of small molecule drugs for the treatment of cancer. The company was founded in 2011 and is headquartered in Brisbane, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Versant Venture Capital VI, L.OwnerAug 12 '24Proposed Sale1.10387,999426,993Aug 13 08:03 AM
Versant Venture Capital VI, L.10% OwnerAug 08 '24Sale1.35400,000540,040597,940Aug 12 08:33 PM
Versant Venture Capital VI, L.10% OwnerAug 12 '24Sale1.10387,999426,993209,941Aug 12 08:33 PM
Versant Venture Capital VI, L.10% OwnerAug 08 '24Proposed Sale18.03400,0007,210,532Aug 09 03:41 PM
Brady Stephen RPresident and CEOJul 03 '24Buy2.1135,00073,85046,376Jul 08 04:15 PM
Whiting SamuelChief Medical OfficerJul 02 '24Buy2.134,6729,9519,573Jul 03 07:35 PM
Trojanowski JustinCorporate ControllerJun 28 '24Buy2.167,50016,20022,168Jul 02 04:15 PM